The Stakeholder Impact of Centralized Trial Services

Clinical trials are becoming more complex, with hybrid designs, global footprints, and expanding vendor ecosystems placing new strain on sponsors, sites, and patients alike. This webinar takes a practical look at how a centralized trial services model can help bring clarity and coordination to that complexity—through the real-world experiences of two sponsors, Cogent and Helus Pharma.

Drawing from active trials across different contexts, the session explores how consolidating patient logistics, site payments, and financial coordination under a single partner reshaped day‑to‑day operations. Speakers share how centralization influenced communication across stakeholders, reduced administrative friction for sites, and improved visibility and oversight at the sponsor level. Rather than focusing on theory, the discussion highlights what changed in practice: where efficiencies emerged, what challenges had to be addressed, and how expectations evolved over the course of the trials.

The conversation begins with a brief overview of why traditional multi‑vendor models are increasingly difficult to manage, then moves into sponsor‑led case examples and concludes with common themes and implementation insights. Attendees will leave with grounded perspectives on when a centralized approach makes sense and what to consider when applying it in live studies.